Serenity Bioworks
Developing therapeutics derived from cellular stress pathways.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Serenity Bioworks Information
Geographic Data
Address:
City: San Francisco
State: California
Zip:
Country: United States
Financial Info
Stage:
seed
Raised Last:
$2M
Raised Total:$2M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Serenity is a therapeutics company focusing on cellular stress pathways. We&s;ve acquired a clinical-stage stress therapeutic, previously known as DC-TAB, based on promising data in MS patients. Based on Serenity&s;s internal efforts, it was discovered that this drug could confer benefit for lupus nephritis, a devastating kidney disorder that afflicts lupus patients. Serenity is now advancing their lead drug under the name SER-101 for lupus nephritis.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2018 | Seed Round | 2 | - |
IndieBio SOSV IndieBio SOSV |
2/2019 | Convertible Note | 2 | - |
IndieBio SOSV IndieBio SOSV |
5/2019 | Seed Round | $2M | 4/2017 | Grant | 1 | $26k |
Velocity Velocity |
2/2019 | Convertible Note | 2 | - |
IndieBio SOSV IndieBio SOSV |
6/2018 | Seed Round | 2 | - |
IndieBio SOSV IndieBio SOSV |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
